Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer’s disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an u…